These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 13433422)

  • 21. Chromatographic studies of purine metabolism. IV. Reversal of azaserine-induced inhibition by phenylalanine and tryptophan.
    TOMISEK AJ; REID MR; SKIPPER HE
    Cancer Res; 1959 Jun; 19(5):489-93. PubMed ID: 13663035
    [No Abstract]   [Full Text] [Related]  

  • 22. Walker carcinosarcoma 256 tissue as a dietary constituent. I. Stimulation of appetite and growth in the tumor-bearing rat.
    MILLAR FK; WHITE J; BROOKS RH; MIDER GB
    J Natl Cancer Inst; 1957 Nov; 19(5):957-87. PubMed ID: 13502752
    [No Abstract]   [Full Text] [Related]  

  • 23. The inhibitory effect of human duodenal filtrates upon the growth of the Walker-256 sarcoma.
    STRAWITZ JG; GLASER BL
    Surg Gynecol Obstet; 1962 Aug; 115():177-81. PubMed ID: 13917717
    [No Abstract]   [Full Text] [Related]  

  • 24. Incorporation of canavanine into protein of Walker carcinosarcoma 256 cells cultured in vitro.
    KRUSE PF; WHITE PB; CARTER HA; McCOY TA
    Cancer Res; 1959 Jan; 19(1):122-5. PubMed ID: 13618897
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of ascites tumor growth by 4-aminopyrazolo-(3,4-d)pyrimidine in combination with azaserine, 6-mercaptopurine, and thioguanine.
    HENDERSON JF; JUNGA IG
    Cancer Res; 1960 Dec; 20():1618-24. PubMed ID: 13713260
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies of a plasma-cell neoplasm of the mouse. I. Characterization of neoplasm 70429, including its sensitivity to various antimetabolites with the rapid development of resistance to azaserine, DON, and N-methylformamide.
    POTTER M; LAW LW
    J Natl Cancer Inst; 1957 Mar; 18(3):413-41. PubMed ID: 13406561
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of combinations of azaserine and of 6-diazo-5-oxo-L-norleucine with purine analogs and other antimetabolites on the growth of two mouse mammary carcinomas.
    TARNOWSKI GS; STOCK CC
    Cancer Res; 1957 Nov; 17(10):1033-9. PubMed ID: 13489704
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of p-phenylenediphosphoric acid tetraethyleneimid, ethyleneiminoacetyl serine and their analogs on various strains of transplanted mammary cancers of mice].
    UCHIDA M; TAKAGI H
    Gan; 1956 Dec; 47(3-4):405-6. PubMed ID: 13415057
    [No Abstract]   [Full Text] [Related]  

  • 29. Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophils.
    Martinelli S; Kostylina G; Niggli V; Baumann C; Fey MF; Wendel HG; Lowe SW; Yousefi S; Simon HU
    Oncogene; 2006 Nov; 25(52):6915-23. PubMed ID: 16715127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of aminooxyacetic acid on extracellular level of D-serine in rat striatum: an in vivo microdialysis study.
    Hashimoto A; Yoshikawa M
    Eur J Pharmacol; 2005 Nov; 525(1-3):91-3. PubMed ID: 16289454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Additive effect of ascorbic acid and glucose analogs on experimental cancer and nucleic acids in tumor tissue.
    SOKOLOFF B; SAELHOF CC; McCONNELL B; SIMPSON M
    Growth; 1958 Mar; 22(1):51-61. PubMed ID: 13562650
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of various compounds upon the growth of transplanted cancer].
    KOSAKA J
    Gan; 1956 Dec; 47(3-4):386-9. PubMed ID: 13415050
    [No Abstract]   [Full Text] [Related]  

  • 33. [Further comments on Filatov's extracts: effect on rats with Walker tumor transplants].
    MAZZETTI G; PASQUINELLI F; CARLONI M
    Sperimentale; 1956; 106(2):169-76. PubMed ID: 13433042
    [No Abstract]   [Full Text] [Related]  

  • 34. [Carinolytic effect of hexamethylolmelamine. III. Studies on Walker carcinoma].
    EICHLER O; STAIB I
    Arzneimittelforschung; 1954 Apr; 4(4):268-70. PubMed ID: 13159726
    [No Abstract]   [Full Text] [Related]  

  • 35. Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation.
    Fisher B; Ravdin RG; Ausman RK; Slack NH; Moore GE; Noer RJ
    Ann Surg; 1968 Sep; 168(3):337-56. PubMed ID: 4970947
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of gastric carcinoma.
    Longmire WP; Kuzma JW; Dixon WJ
    Ann Surg; 1968 Mar; 167(3):293-312. PubMed ID: 4966925
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of colorectal carcinoma.
    Holden WD; Dixon WJ; Kuzma JW
    Ann Surg; 1967 Apr; 165(4):481-503. PubMed ID: 4960423
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of cancer inhibitor drugs on the take of Walker carcinosarcoma 256 in rats.
    MCDONALD GO; CRUZ EP; COLE WH
    Surg Forum; 1957; 7():486-9. PubMed ID: 13433422
    [No Abstract]   [Full Text] [Related]  

  • 39. A rat tumour useful in experimental cancer chemotherapy.
    Khandalekar DD; Ambaye RY; Panse TB
    Indian J Cancer; 1966 Mar; 3(1):43-8. PubMed ID: 5936016
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the effect of azaserine and azaserine with 6-mercaptopurine on the Yoshida sarcoma].
    YAMAGUCHI H; KURAHORI T; KUSUMOTO G; TERASHITA N; TABUCHI Y; ICHIHARA G; TOKITA Y; IKEDA E; FUKUI S
    Gan; 1956 Dec; 47(3-4):385-6. PubMed ID: 13415049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.